• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Healthcare Organizations Support Digital Health Collaborative's Initiative to Advance Digital Health Solutions

News
Article

This new initiative brings together provider groups, purchasers and end users committed to evidence-based, cost-effective, equitable digital health solutions.

In a time where the demand for digital health technologies is needed, the Digital Health Collaborative, a new organization dedicated to advancing the evidence and adoption of digital health solutions, has gained support from 14 leading healthcare and consumer organizations.

© stock.adobe.com

© stock.adobe.com

Despite advancements in this space, purchasers are challenged with determining the best solutions for their digital health needs.

This new initiative brings together provider groups, purchasers and end users committed to evidence-based, cost-effective, equitable digital health solutions.

The Peterson Health Technology Institute (PHTI), an initiative of the Peterson Center on Healthcare, is a supporter of the Collaborative.

PHTI assesses digital health solutions to determine their clinical effectiveness and financial impact for purchasers like payers, providers, and employers on behalf of patients.

Meg Baron, managing director of engagement and outreach at PHTI shared with Managed Healthcare Executive, "Collaborative members will jointly work together on research, programs, and knowledge sharing to help raise purchaser confidence and adoption of digital health solutions. Initial activities will include a national survey of digital health purchasers, grantmaking through a Research and Impact Fund, and regular convenings, including at an annual Summit."

Collaborative members include:

  • AARP
  • AHIP
  • Alliance for Connected Care
  • American Medical Association (AMA)
  • American Telemedicine Association (ATA)
  • Consumer Technology Association (CTA)
  • Digital Medicine Society (DiMe)
  • Digital Therapeutics Alliance (DTA)
  • HLTH Foundation
  • Innovation and Value Initiative (IVI)
  • International Consortium for Health Outcomes Measurement (ICHOM)
  • National Alliance of Healthcare Purchaser Coalitions
  • The National Committee for Quality Assurance (NCQA)
  • RockHealth.org

Through support from PHTI, the Collaborative will offer the Research and Impact Fund for aligned research and programs.

The first grant was awarded to DiMe for its Integrated Evidence Plans for Digital Health Products project to help developers align digital health products with purchaser evidence requirements.

“With a growing market of digital health solutions available to providers and consumers, the Digital Health Collaborative will play an important role in helping to bring together the perspectives and voices across the health system to meaningfully share insights on new and emerging technology,” Danielle Lloyd, senior vice president of Private Market Innovations and Quality at AHIP, said. “We hope the Collaborative’s research, analysis and data initiatives can help fill important gaps in assessing clinical value and health outcomes for stakeholders across the health system.”

Related Videos
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Video 8 - "Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization"
Video 7 - "Prescribing Prescription Drug Therapeutics: Factors for Providers and Payers to Consider"
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
© 2024 MJH Life Sciences

All rights reserved.